■ 学術雑誌
|
原著
|
|
1.
|
Hayato S, Hamuro L, Shimizu T, Yonemori K, Nishio S, Yunokawa M, Yoshida T,
Nishio M, Matsumoto K, Takehara K, Hasegawa K, Kozuki T, Hirashima Y, Kato H,
Miura T, Nomoto M, Zhao Y, Zhu L, Yasuda S.：
Pharmacokinetic and Exposure-Response Modeling Support Body Surface Area-Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors.
Journal of clinical pharmacology
65
(6)
：751
-762
, 2025
|
|
2.
|
Merel J J Lucassen, Pedro Bergmann, Olga Husson, Udai Banerji, Bristi Basu, Ignacio Melero, Emiliano Calvo, Philippe A Cassier, Alexander Drilon, Peter C Fong, Elena Garralda, Anthony M Joshua, Chia-Chi Lin, Juanita Lopez, Victor Moreno, Anna Minchom, Ruth Plummer, Sophie Postel-Vinay, Anna Spreafico, Toshio Shimizu, Timothy A Yap, Christina Yap, Johann S De Bono, Neeltje Steeghs：
Barriers to publishing early phase clinical trials: the oncologists' perspective.
The oncologist
30
(4)
：oyaf042
, 2025
|
|
その他
|
|
1.
|
生駒 龍興, 清水 俊雄：
薬理学・毒性学 二重特異性抗体の開発状況と今後の展望.
医学のあゆみ
296
(7)
：719
-720
, 2026
|
|
■ 学会発表
|
国際学会及び海外の学会
|
|
1.
|
◎Tatsuki Ikoma, Keigo Araki, Mai Kitagawa, Natsuno Makihara, Yutaro Nagata, Kazuki Fujii, Kahori Nakahama, Yuki Takeyasu, Utae Katsushima, Yuta Yamanaka, Hiroshige Yoshioka, Toshio Shimizu, Takayasu Kurata：
AGTR1 inhibition enhances the effectiveness of chemo-immunotherapy in non-squamous non-small cell lung cancer.
ESMO Targeted Anticancer Therapies Asia Congress 2025,
香港,
2025/07
|
|
